Stephen H. Willard

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Paul Lehr, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen H. Willard:

Company Role Class Num Shares Value Price $ Report Date Ownership
Longeveron Inc. Chief Executive Officer Class A Common Stock 294,467 $156,067 $0.5300 02 Mar 2026 Direct
NRX Pharmaceuticals, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock, par value $0.001 per share 50,000 $15,995 $0.3199 16 Dec 2022 Direct
Longeveron Inc. Chief Executive Officer Stock Option (right to buy) 200,000 02 Mar 2026 Direct

Insider Reports Filed by Stephen H. Willard

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LGVN Longeveron Inc. 02 Mar 2026 4 $0 4 Chief Executive Officer 13 Mar 2026, 20:59
LGVN Longeveron Inc. 11 Feb 2026 0 $0 3 Chief Executive Officer 13 Mar 2026, 20:58
NRXP NRX Pharmaceuticals, Inc. 16 Dec 2022 1 +$58,500 4 CHIEF EXECUTIVE OFFICER, Director 19 Dec 2022, 06:14
NRXP NRX Pharmaceuticals, Inc. 12 Jul 2022 0 $0 3 Chief Executive Officer, Director 22 Jul 2022, 16:27